Combination of177Lu-lilotomab with rituximab significantly improves the therapeutic outcome in preclinical models of non-Hodgkin's lymphoma-Reference-Cited by-同舟云学术

Combination of177Lu-lilotomab with rituximab significantly improves the therapeutic outcome in preclinical models of non-Hodgkin's lymphoma

Published:2018-08-31 Issue:4 Volume:101 Page:522-531
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Repetto-Llamazares Ada H. V.¹^ORCID,Malenge Marion M.¹²³,O'Shea Adam¹,Eiríksdóttir Bergthóra⁴,Stokke Trond²,Larsen Roy H.⁵,Dahle Jostein¹

Affiliation:

1. Nordic Nanovector ASA; Oslo Norway

2. Department of Radiation Biology; Institute for Cancer Research; Oslo University Hospital; Oslo Norway

3. Institute of Clinical Medicine; Faculty of Medicine; University of Oslo; Oslo Norway

4. ArcticLAS Ltd. CRO; Reykjavík Iceland

5. Sciencons AS; Oslo Norway

Funder

Norges Forskningsråd

Nordic Nanovector ASA

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.13139/fullpdf

Reference51 articles.

1. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma;Maloney;Blood,1997

2. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study;Coiffier;Blood,1998

3. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte;Coiffier;Blood,2010

4. Rituximab in lymphoma: a systematic review and consensus practice guideline from Cancer Care Ontario;Cheung;Cancer Treat Rev,2007

5. NCCN Guidelines Non-Hodgkin's Lymphomas 2017

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent preclinical and clinical advances in radioimmunotherapy for non-Hodgkin’s lymphoma;Exploration of Targeted Anti-tumor Therapy;2024-02-28

2. Radioimmunotherapy;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

3. Therapeutic Monoclonal Antibodies for Non-Hodgkin Lymphoma: A Literature Review;Current Cancer Therapy Reviews;2024-01

4. NNV024, a novel humanized anti-CD37 antibody with enhanced ADCC and prolonged plasma half-life in human FcRn transgenic mice for treatment of NHL;2023-07-12

5. Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update;Seminars in Nuclear Medicine;2023-05